Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

A single treatment with a CRISPR-Cas9 based gene editing therapy is enough to replace the daily medication of patients with ...

He calls it ‘a very, very serious issue.’ The wide-ranging agreement is expected to usher in advanced new weaponry at a time when defense budgets are tight and the long-term reliability of the ...

Signaturefd LLC trimmed its position in Consolidated Edison, Inc. (NYSE:ED – Free Report) by 1.2% during the third quarter, ...